Testing a heart pacing method with specific new devices
Part of Heart & circulation clinical trials.
This trial studies how safe and effective a newer type of heart pacing (LBBaP) is when using two specific commercial devices. It may help people who are getting their first permanent pacemaker or heart-resynchronization treatment (CRT) by comparing outcomes after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- This would be your first time getting a permanent pacemaker or CRT.
- Your doctor plans to place the LBBaP pacing lead as part of this study.
- You can and agree to return for follow-up visits at the study site(s).
- You agree to take part and sign the study consent form.
- You are not in another intervention clinical trial and you are available for this trial’s schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of pacemaker system that delivers pacing to the left side of the heart through a lead placed deep in the wall between the lower chambers. The goal is to see if this approach works well for people who need a pacemaker or CRT.
This trial tests if a newer pacing method called left bundle branch area pacing works as well as standard cardiac resynchronization therapy (CRT) for people with heart failure and a specific heart blockage (left bundle branch block). It aims to offer an effective treatment option with potentially easier setup.
This trial tests a new pacing approach that combines a left bundle branch pacemaker with standard cardiac resynchronization therapy (CRT) for people with heart failure. It aims to improve the heart's pumping efficiency compared to using the left bundle branch pacemaker alone.
This trial compares two types of pacemaker placement to improve heart function in people with heart failure. One method paces the heart's natural conduction system, while the other paces the lower chambers of the heart. The goal is to find which approach works better for heart resynchronization therapy.
This study is testing a portable heart monitoring device to help doctors check how well a special pacemaker (LBBAP) is working. It may help people who need a new or upgraded pacemaker or heart device.
This trial tests whether a different pacing approach called left bundle branch pacing can improve outcomes and heart structure changes in people who did not improve with standard biventricular CRT. It may help some patients with ongoing heart failure symptoms and weak heart pumping.
Hear when a new Consented to Participate in the Trial and Signed an ICF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.